- Home
- Publications
- Publication Search
- Publication Details
Title
New perspectives on CKD-induced dyslipidemia
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 21, Issue 10, Pages 967-976
Publisher
Informa UK Limited
Online
2017-08-22
DOI
10.1080/14728222.2017.1369961
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism
- (2017) Hua Chen et al. JOURNAL OF PROTEOME RESEARCH
- Metabolomics for clinical use and research in chronic kidney disease
- (2017) Berthold Hocher et al. Nature Reviews Nephrology
- The link between phenotype and fatty acid metabolism in advanced chronic kidney disease
- (2017) Dan-Qian Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
- (2017) Dan-Qian Chen et al. Redox Biology
- Metabolic biomarkers for chronic kidney disease
- (2016) Marc Breit et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease
- (2016) Lidia Anguiano et al. ATHEROSCLEROSIS
- Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
- (2016) Gissette Reyes-Soffer et al. CIRCULATION
- A combined non-targeted and targeted metabolomics approach to study the stereoselective metabolism of benalaxyl enantiomers in mouse hepatic microsomes
- (2016) Xinru Wang et al. ENVIRONMENTAL POLLUTION
- Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?
- (2016) Anna Gluba-Brzózka et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease
- (2016) Hirokazu Honda et al. Journal of Atherosclerosis and Thrombosis
- Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans
- (2016) Zhi-Hao Zhang et al. JOURNAL OF PROTEOME RESEARCH
- Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study
- (2016) Barbara Kollerits et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dyslipidemia in patients with chronic kidney disease
- (2016) Matthew R. Hager et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review
- (2016) David Collister et al. SEMINARS IN NEPHROLOGY
- Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients
- (2016) Hao Shen et al. BMC Nephrology
- Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
- (2016) Nans Florens et al. Toxins
- Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
- (2016) Hua Chen et al. Redox Biology
- Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
- (2015) Valvanera Fernández-Laso et al. ATHEROSCLEROSIS
- Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference
- (2015) Marisa Martín et al. ATHEROSCLEROSIS
- Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease
- (2015) Clara Barrios et al. ATHEROSCLEROSIS
- Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD
- (2015) M. Gracia et al. Clinical Journal of the American Society of Nephrology
- Dialysis Modalities and HDL Composition and Function
- (2015) M. Holzer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL particle number and size as predictors of cardiovascular disease
- (2015) Anatol Kontush Frontiers in Pharmacology
- Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis and Nrf2 dysfunction in aristolochic acid-induced nephropathy
- (2015) Ying-Yong Zhao et al. Scientific Reports
- UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry
- (2014) Ying-Yong Zhao et al. CLINICAL BIOCHEMISTRY
- HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
- (2014) R. Shroff et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
- (2014) Christoph Wanner et al. KIDNEY INTERNATIONAL
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study
- (2014) A. Betriu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study
- (2014) David Arroyo et al. BMC Nephrology
- Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
- (2013) Stanley Ip ANNALS OF INTERNAL MEDICINE
- Clinical and research markers of oxidative stress in chronic kidney disease
- (2013) Patrick Steven Tucker et al. BIOMARKERS
- Metabolomics in chronic kidney disease
- (2013) Ying-Yong Zhao CLINICA CHIMICA ACTA
- Lipoprotein metabolism and CKD: overview
- (2013) Philip Barter Clinical and Experimental Nephrology
- Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management
- (2013) Sudarshan Balla et al. CURRENT OPINION IN PHARMACOLOGY
- Lipidomics applications in health, disease and nutrition research
- (2013) Sharon A. Murphy et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—A meta-analysis of 11 randomized controlled trials involving 21,295 participants
- (2013) Marcin Barylski et al. PHARMACOLOGICAL RESEARCH
- STATISTICAL METHODS FOR THE ANALYSIS OF HIGH-THROUGHPUT METABOLOMICS DATA
- (2013) Jörg Bartel et al. Computational and Structural Biotechnology Journal
- CKD and Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapeutic Approaches
- (2012) I. R. Whitman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Chronic Inflammatory Disorders and Accelerated Atherosclerosis: Chronic Kidney Disease
- (2011) Kaveh D. Navab et al. CURRENT PHARMACEUTICAL DESIGN
- Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans
- (2011) Shusaku Maeda et al. Journal of Atherosclerosis and Thrombosis
- Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
- (2011) James D. Otvos et al. Journal of Clinical Lipidology
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- Systems biology of kidney diseases
- (2011) John Cijiang He et al. KIDNEY INTERNATIONAL
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Metabolomics in the study of kidney diseases
- (2011) Robert H. Weiss et al. Nature Reviews Nephrology
- Lipid Abnormalities and Oxidized LDL in Chronic Kidney Disease Patients on Hemodialysis and Peritoneal Dialysis
- (2011) Elisabeth C. Samouilidou et al. RENAL FAILURE
- Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study
- (2010) Mireia Junyent et al. BMC Nephrology
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors
- (2007) A Negre-Salvayre et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started